Johanna CFA - Schroders PLC CoHead Officer
| SDR Stock | 315.00 4.00 1.29% |
Executive
Johanna CFA is CoHead Officer of Schroders PLC
| Age | 48 |
| Address | 1 London Wall Place, London, United Kingdom, EC2Y5AU |
| Phone | 44 20 7658 6000 |
| Web | https://www.schroders.com |
Schroders PLC Management Efficiency
The company has return on total asset (ROA) of 0.0186 % which means that it generated a profit of $0.0186 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0896 %, meaning that it generated $0.0896 on every $100 dollars invested by stockholders. Schroders PLC's management efficiency ratios could be used to measure how well Schroders PLC manages its routine affairs as well as how well it operates its assets and liabilities. At present, Schroders PLC's Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to about 21.7 B, whereas Total Current Assets are forecasted to decline to about 5.2 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jens Rasmussen | Coor Service Management | 56 | |
| Fiona Bor | Mereo BioPharma Group | N/A | |
| Jackie Parkin | Mereo BioPharma Group | 66 | |
| Charlotte Almberg | Coor Service Management | N/A | |
| Jeffrey Berkley | Surgical Science Sweden | 55 | |
| Martin Jansson | Surgical Science Sweden | 53 | |
| Cla Rosenfeld | Oncimmune Holdings plc | N/A | |
| Sofia Nilsson | Coor Service Management | N/A | |
| John Lewicki | Mereo BioPharma Group | 72 | |
| BSc FRCP | Oncimmune Holdings plc | N/A | |
| Adv | Surgical Science Sweden | 56 | |
| Suba Krishnan | Mereo BioPharma Group | 59 | |
| Alexandra HughesWilson | Mereo BioPharma Group | 53 | |
| Inbal MazorBadichi | Surgical Science Sweden | 55 | |
| Christine CPA | Mereo BioPharma Group | 43 | |
| James MD | Oncimmune Holdings plc | N/A | |
| MD BSc | Oncimmune Holdings plc | N/A | |
| Anna Ahlberg | Surgical Science Sweden | 54 | |
| Bo Kara | Mereo BioPharma Group | N/A | |
| Frida Sandgren | Coor Service Management | N/A | |
| Maarten Brusse | Oncimmune Holdings plc | N/A | |
Management Performance
| Return On Equity | 0.0896 | ||||
| Return On Asset | 0.0186 |
Schroders PLC Leadership Team
Elected by the shareholders, the Schroders PLC's board of directors comprises two types of representatives: Schroders PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Schroders. The board's role is to monitor Schroders PLC's management team and ensure that shareholders' interests are well served. Schroders PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Schroders PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Emily Li, Head Relations | ||
| Sara Dunne, Director Communications | ||
| Estelle Bibby, Head Relations | ||
| Meagen Burnett, Group Officer | ||
| CFA CFA, CoHead Officer | ||
| Richard Keers, CFO Director | ||
| Samir Ali, Ex Officer | ||
| John Roche, VP Relations | ||
| Richard Oldfield, Group Director | ||
| Grant Creed, Ex CFO | ||
| Peter Harrison, Group Director | ||
| Emma Holden, Global Resources | ||
| Neil Tomlinson, Group Counsel | ||
| Alex James, Investor Manager | ||
| Sonia Jenkins, Chief Officer | ||
| Beth Saint, Global Communications | ||
| Howard Trust, G Counsel | ||
| Leif Nelson, Chief VP | ||
| Jamie Ovenden, Chief Officer | ||
| Rory Bateman, CoHead Equities | ||
| Mark Hemenetz, Chief Unit | ||
| Johanna CFA, CoHead Officer | ||
| Simon Johnson, Pres CEO | ||
| David Warwick, Director Relations | ||
| Torsten SauerPetersen, Ex HR |
Schroders Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Schroders PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0896 | ||||
| Return On Asset | 0.0186 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 194.71 M | ||||
| Shares Outstanding | 1.55 B | ||||
| Shares Owned By Insiders | 43.13 % | ||||
| Shares Owned By Institutions | 34.75 % | ||||
| Price To Book | 1.11 X | ||||
| Price To Sales | 1.67 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Schroders Stock
Schroders PLC financial ratios help investors to determine whether Schroders Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Schroders with respect to the benefits of owning Schroders PLC security.